These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2942844

  • 1. Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetes.
    Fagan TC, Nelson EB, Lasseter KC, Crook J, Morledge J, Conrad KA.
    Pharmacotherapy; 1986; 6(3):128-36. PubMed ID: 2942844
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC, Sternleib C, Vlachakis N, Deedwania PC, Mehta JL.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [Abstract] [Full Text] [Related]

  • 3. A double-blind randomized cross-over study of the efficacy and tolerability of nifedipine and nitrendipine in the treatment of mild to moderate hypertension.
    Heagerty AM, Swales JD.
    Br J Clin Pharmacol; 1989 Apr; 27(4):411-6. PubMed ID: 2655687
    [Abstract] [Full Text] [Related]

  • 4. Amiloride compared with nitrendipine in treatment of essential hypertension.
    Katzman PL, Henningsen NC, Hulthén UL.
    J Hum Hypertens; 1988 Oct; 2(3):147-51. PubMed ID: 3236318
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension.
    Spieker C.
    Blood Press Suppl; 1998 Oct; 1():15-21. PubMed ID: 9660522
    [Abstract] [Full Text] [Related]

  • 6. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE.
    Drugs; 1987 Oct; 34 Suppl 3():97-106. PubMed ID: 2894980
    [Abstract] [Full Text] [Related]

  • 7. Altered pressor responses in long-term nitrendipine treatment.
    Simon G, Snyder DK.
    Clin Pharmacol Ther; 1984 Sep; 36(3):315-9. PubMed ID: 6380880
    [Abstract] [Full Text] [Related]

  • 8. Experience with nitrendipine--a new calcium antagonist--in hypertension.
    Andrén L, Hansson L, Orö L, Ryman T.
    J Cardiovasc Pharmacol; 1982 Sep; 4 Suppl 3():S387-91. PubMed ID: 6184574
    [Abstract] [Full Text] [Related]

  • 9. Effects of nitrendipine and enalapril on left ventricular mass in patients with non-insulin-dependent diabetes mellitus and hypertension.
    Gerritsen TA, Bak AA, Stolk RP, Jonker JJ, Grobbee DE.
    J Hypertens; 1998 May; 16(5):689-96. PubMed ID: 9797181
    [Abstract] [Full Text] [Related]

  • 10. Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.
    Maclean D, Mitchell ET, Lewis R, Irvine N, McLay JS, McEwen J, Coulson RR, Slater ND, Fitzsimons TJ, McDevitt DG.
    Br J Clin Pharmacol; 1990 Apr; 29(4):455-63. PubMed ID: 2183868
    [Abstract] [Full Text] [Related]

  • 11. Nitrendipine once or twice daily in hypertensive non-insulin-dependent diabetes mellitus.
    Dolben J, Vora J, Smith H, Luzio S, Griffiths D, Vølund A, Owens DR.
    J Cardiovasc Pharmacol; 1991 Apr; 18 Suppl 1():S94-7. PubMed ID: 1723468
    [Abstract] [Full Text] [Related]

  • 12. Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. German Reserpine in Hypertension Study Group.
    Krönig B, Pittrow DB, Kirch W, Welzel D, Weidinger G.
    Hypertension; 1997 Feb; 29(2):651-8. PubMed ID: 9040452
    [Abstract] [Full Text] [Related]

  • 13. Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients.
    Argenziano L, Izzo R, Iovino G, De Luca N, Parrella L, Morisco C, Trimarco B.
    Blood Press Suppl; 1998 Feb; 1():9-14. PubMed ID: 9660521
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study Group.
    Bolli P, Cobby J, Handa SP, LaPlante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM.
    Can J Cardiol; 1991 Mar; 7(2):59-64. PubMed ID: 2049684
    [Abstract] [Full Text] [Related]

  • 15. Nitrendipine vs. long-acting nifedipine in mild, moderate and severe hypertension.
    Guazzi MD, De Cesare N, Galli C, Tamborini G, Salvioni A.
    Angiology; 1986 Jul; 37(7):508-18. PubMed ID: 2942062
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
    Jain AK, McMahon FG, Ryan JR, Maronde R, Vlachakis N, Mroczek W.
    J Cardiovasc Pharmacol; 1984 Jul; 6 Suppl 7():S1053-9. PubMed ID: 6085366
    [Abstract] [Full Text] [Related]

  • 17. Once- vs. twice-daily nitrendipine in the treatment of mild to moderate hypertension, Canadian Nitrendipine Study Group.
    Bolli P, Cobby J, Handa SP, Laplante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM.
    J Cardiovasc Pharmacol; 1991 Jul; 17 Suppl 2():S182-5. PubMed ID: 1715478
    [Abstract] [Full Text] [Related]

  • 18. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA, Drayer JI.
    J Cardiovasc Pharmacol; 1984 Jul; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine.
    Johnson BF, Romero L, Marwaha R.
    Clin Pharmacol Ther; 1986 Apr; 39(4):389-94. PubMed ID: 2937598
    [Abstract] [Full Text] [Related]

  • 20. Calcium antagonist antihypertensive treatment of non-insulin-dependent diabetics: efficacy and safety of lacidipine versus nifedipine SR.
    Gulizia M, Valenti R, Platania F, D'Onofrio V, Rizzini P, Circo A.
    J Cardiovasc Pharmacol; 1994 Apr; 23 Suppl 5():S101-4. PubMed ID: 7609494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.